Senior insider sale
RECURSION PHARMACEUTICALS, INC. — senior position signals high conviction
$961.4K
220K shares
What this filing means
BORGESON BLAKE plans to sell 220K shares of RECURSION PHARMACEUTICALS, INC. valued at approximately $961.4K. Form 144 is a notice of intent to sell restricted or control securities — not a mandatory transaction. This filing provides advance warning of potential selling pressure.
Filed: 12/2/2025ACC: 0001959173-25-007422
Director
Since Apr 2021
220K
Shares to sell
$961.4K
Approx. market value
220K
Acquired (3 months)
1
Planned
Securities Acquired — Last 3 Months2
Founders Shares
Compensation
9/1/2017
110KFounders Shares
Compensation
9/1/2016
110KTotal acquired220K
| Acquisition Date | Type | Amount Acquired | Gift |
|---|---|---|---|
9/1/2017 | Founders Shares Compensation | 110K | — |
9/1/2016 | Founders Shares Compensation | 110K | — |
| Total | 220K | ||
Planned & Completed Dispositions1
NASDAQPlanned
Units to sell
220K
Market value
$961.4K
12/2/2025
Total
Units
220K
Value
$961.4K
| Date | Units to Sell | Approx. Market Value | Exchange | Status |
|---|---|---|---|---|
12/2/2025 | 220K | $961.4K | NASDAQ | Planned |
| Total | 220K | $961.4K | ||